Background Uganda has one of the highest age-standardized incidence rates of cervical
cancer in the world. The proportion of Ugandan women screened for cervical cancer is low …

Cervical cancer is a critical public health issue in sub-Saharan Africa (SSA), where it is the
second leading cause of cancer among women and the leading cause of female cancer …

It is estimated that more than 311 000 women die of cervical cancer each year. Of these
deaths, 91% occur in low-and middle-income countries. Demographic changes and a lack of …

When cost-effective interventions are unaffordable: Integrating cost-effectiveness and
budget impact in priority setting for global health programs | PLOS Medicine Skip to main …

Cervical cancer (CC) is a major health care problem in low-and middle-income countries,
necessitating the development of low-cost and easy-to-use assays for CC detection at point …

Management algorithms for screen‐positive women in cervical cancer prevention programs
have undergone substantial changes in recent years. The WHO strongly recommends …

Objective To estimate the health impact, financial costs, and cost‐effectiveness of scaling‐up
coverage of human papillomavirus (HPV) vaccination (young girls) and cervical cancer …

Cervical cancer (CC) is the leading cause of cancer‐related death among women in sub‐
Saharan Africa, primarily because of limited access to effective screening and preventive …

It has been shown that γδ T cells protect against the formation of squamous cell carcinoma
(SCC) in several models. However, the role of γδ T cells in human papillomavirus (HPV) …

Persistent high-risk HPV infection is the main cause of cervical cancer. The HPV oncogene
E7 plays an important role in HPV carcinogenesis. Currently, HPV vaccines do not offer an …